Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.099
Bid: 0.0972
Ask: 0.102
Change: 0.00 (0.00%)
Spread: 0.0048 (4.938%)
Open: 0.099
High: 0.00
Low: 0.00
Prev. Close: 0.099
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

10 Jan 2024 11:29

RNS Number : 2717Z
Versarien PLC
10 January 2024
 

10 January 2024

Versarien Plc

("Versarien" or the "Company")

Result of General Meeting

Versarien Plc (AIM: VRS), the advanced materials engineering group, is pleased to confirm that at the Company's General Meeting held earlier today, all resolutions were duly passed. Full details of the resolutions are set out in the Notice of General Meeting dated 20 December 2023 and available on the Company's website at: https://www.versarien.com/investors/reports-and-presentations/

The proxy votes cast were as follows:

Resolution

 

For

 

 

Against

 

 

Abstain

1 - to sub-divide each Existing

Ordinary Share into one New Ordinary Share and one New Deferred Share

 

22,939,297

93.25%

1,661,734

6.75%

303,606

2 - a special resolution to alter the Articles to allow for the issue of New Deferred Shares by including provisions relating to the rights and restrictions attached to the New Deferred Shares

 

22,992,555

93.78%

1,524,588

6.22%

387,494

3 - to grant the directors authority to allot up to 992,339,000 New Ordinary Shares

 

22,754,233

93.16%

1,670,424

6.84%

479,980

4 - a special resolution to grant the directors authority to allot up to 992,339,000 New Ordinary Shares for cash without first offering them to existing shareholders

 

22,530,861

92.30%

1,880,416

7.70%

493,360

 

Share Capital Reorganisation

Following the passing of the resolutions at the General Meeting, each of the Company's 496,169,507 Existing Ordinary Shares will be sub-divided into one New Ordinary Share of 0.01p (the "New Ordinary Shares") and one deferred share of 0.09p ("New Deferred Shares"). The New Deferred Shares will have little economic value as they will not carry any rights to vote or dividend rights, although the New Deferred Shares will rank pari passu with the New Ordinary Shares on a return of capital or on a winding up of the Company.

 

Admission to AIM and Total Voting Rights

Dealings on AIM in the Existing Ordinary Shares is expected to cease at the close of business on 10 January 2024. Application has been made for the admission of 496,169,507 New Ordinary Shares to trading on AIM ("Admission") and it is expected that Admission will take place and that trading in the New Ordinary Shares will commence at 8.00 a.m. on or around 11 January 2024. No application will be made for admission of the New Deferred Shares to trading on AIM nor will any such application be made to any other exchange.

Following Admission, there will be a total of 496,169,507 New Ordinary Shares, with voting rights, in issue. The Company does not hold any shares in treasury. Consequently, 496,169,507 is the figure which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Unless otherwise indicated, all defined terms in this announcement shall have the same meaning as described in the Company's announcement dated 20 December 2023 and the Circular which was posted to shareholders on the same day.

For further information please contact:

 

Versarien

Stephen Hodge, Chief Executive Officer

Chris Leigh, Chief Financial Officer

 

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

 

+44 (0)20 3470 0470

 

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

For further information please see: http://www.versarien.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMGPURPGUPCGGU
Date   Source Headline
7th Jun 20182:00 pmRNSPrice Monitoring Extension
7th Jun 20187:00 amRNSVersarien appointed to NGA Industry Council
29th May 20187:00 amRNSConsumer Goods Collaboration
22nd May 20187:00 amRNSAppointment of senior DIT secondee
4th May 20187:00 amRNSChange of Nominated Adviser and Broker
30th Apr 20187:00 amRNSAgreement with Luxus
16th Apr 20187:25 amRNSGraphene Supply to Major Tyre Producer
3rd Apr 20181:32 pmRNSHolding(s) in Company
28th Mar 20187:00 amRNSHexotene Product Launch
27th Mar 20187:00 amRNSCollaboration with World Leading Aerospace Group
14th Mar 20187:00 amRNSCollaboration with Team Sky
7th Mar 20181:15 pmRNSAdditional Investor Event
7th Mar 20187:00 amRNSInvestor Event
27th Feb 20184:41 pmRNSSecond Price Monitoring Extn
27th Feb 20184:35 pmRNSPrice Monitoring Extension
27th Feb 20187:00 amRNSAgreement with Vivobarefoot
21st Feb 20187:00 amRNSMedical Technology Collaboration
5th Feb 20187:00 amRNSAppointment to US National Graphene Advisory Board
2nd Feb 20184:40 pmRNSHolding(s) in Company
29th Jan 20183:18 pmRNSExercise of Options
23rd Jan 20183:33 pmRNSHolding(s) in Company
15th Jan 20182:05 pmRNSSecond Price Monitoring Extn
15th Jan 20182:00 pmRNSPrice Monitoring Extension
15th Jan 201811:05 amRNSSecond Price Monitoring Extn
15th Jan 201811:00 amRNSPrice Monitoring Extension
15th Jan 20189:05 amRNSSecond Price Monitoring Extn
15th Jan 20189:00 amRNSPrice Monitoring Extension
15th Jan 20187:00 amRNSPlanned Chinese graphene manufacturing facility
8th Jan 20187:00 amRNSAgreement with Global Apparel Manufacturer
5th Jan 201811:05 amRNSDirector/PDMR Shareholding
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
7th Dec 20177:00 amRNSExercise of Options
4th Dec 201711:05 amRNSSecond Price Monitoring Extn
4th Dec 201711:00 amRNSPrice Monitoring Extension
4th Dec 20179:00 amRNSPrice Monitoring Extension
4th Dec 20177:00 amRNSAgreement with Global Chemical Major
1st Dec 20172:05 pmRNSSecond Price Monitoring Extn
1st Dec 20172:00 pmRNSPrice Monitoring Extension
29th Nov 20177:00 amRNSInterim Results
28th Nov 20172:05 pmRNSSecond Price Monitoring Extn
28th Nov 20172:00 pmRNSPrice Monitoring Extension
21st Nov 20179:05 amRNSSecond Price Monitoring Extn
21st Nov 20179:00 amRNSPrice Monitoring Extension
17th Nov 20177:00 amRNSCollaboration with Global Consumer Goods Company
7th Nov 20174:40 pmRNSSecond Price Monitoring Extn
7th Nov 20174:35 pmRNSPrice Monitoring Extension
7th Nov 20173:07 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSSuccessful Fundraising of £2.9 million
3rd Nov 20174:43 pmRNSFundraising of approximately £1.2 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.